Jeffrey W. Albers, Director at Blueprint Medicines Corp (BPMC), sold 39,404 shares at $85.12 ($3.4M) on 2024-09-09, disclosed to the SEC on 2024-09-11.
Scheduled sale ($3.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.12 | 7,734 | $658K | 19.5% |
| 2 | $85.12 | 7,734 | $658K | 19.5% |
| 3 | $85.86 | 11,968 | $1.0M | 30.5% |
| 4 | $85.86 | 11,968 | $1.0M | 30.5% |
| Total | $85.57 avg | 39,404 | $3.4M | 100% |
| Filing → |
| KYMR | SELL | 2025-10-14 | $296K | — | Filing → |
| KYMR | SELL | 2025-06-03 | $311K | — | Filing → |
| BPMC | SELL | 2025-05-29 | $572K | — | Filing → |